BVF Partners
Signal active
Investment Firm
Overview
BVF Partners invests in small-cap biotechnology companies and serves customers in the United States.
Highlights
Founded
Invalid date
Industry
Employees
0
Investment
22
Lead Investment
9
Exits
10
Stages
Late Stage Venture, Early Stage Venture, Private Equity
Investor Type
Hedge Fund, Private Equity Firm
Location
United States, North America
Contact Information
Social
N/A
Profile Resume
BVF Partners, established in Unknown year and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Private Equity investments across Biotechnology, Health Care, Therapeutics, Financial Services, Venture Capital, Finance, Life Science, FinTech, Biopharma, Business Development. The organization boasts a portfolio of 18 investments, with an average round size of $116.6M and 10 successful exits. Their recent investments include Tenax Therapeutics, Vivo Capital, Autobahn Therapeutics, Canaan Partners, ARCH Venture Partners. The highest investment round they participated in was $277.1B. Among their most notable exits are Tenax Therapeutics and Vivo Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
BVF Partners has made 22 investments. Their most recent investment was on Aug 06, 2024, when Tenax Therapeutics raised $100.0M.
BVF Partners has made 2 diversity investments. Their most recent diversity investment was on Nov 28, 2023, when Aro Biotherapeutics raised $41.5M.
investments
22
Diversity investments
2
Lead investments
9
Number of exits
10
Investments
22
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| May 30, 2024 | Celcuity | Biotechnology | 60.0M |
| Jul 23, 2024 | - | - | 165.0M |
| Jul 24, 2024 | Autobahn Therapeutics | Biotechnology | 100.0M |
| Aug 06, 2024 | Tenax Therapeutics | Biotechnology | 100.0M |
CelcuityExits
10
Funding Timeline
Funding rounds
22
Investors
0
Funds
0
Funding Rounds
22
BVF Partners has raised 22 rounds. Their latest funding was raised on Aug 06, 2024 from a Post-IPO Equity - Tenax Therapeutics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| May 30, 2024 | Post-IPO Equity - Celcuity | - | 60.0M | - |
| Jul 23, 2024 | Series A - Third Arc Bio | - | 165.0M | - |
| Jul 24, 2024 | Series C - Autobahn Therapeutics | - | 100.0M | - |
| Aug 06, 2024 | Post-IPO Equity - Tenax Therapeutics | - | 100.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.